The purpose of this guidance is to describe the recommendations of the Center for Biologics Evaluation and Research (CBER) on the use of standards in product development and control as well as the use of such standards in CBER’s managed review process. CBER, Biologics
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/vAGXWIR
No comments:
Post a Comment